mood stabilizer augmentation
-
antipsychotics, BPRS, Drugs, hypoglycemia, lithium, mood stabilizer augmentation, pancytopenia, psychopharmacology, schizophrenia, treatment-resistant schizophrenia, valproateLithium vs. Valproate in Residual Schizophrenia: Case Safety Signal
A 2026 case report described valproate 800 mg/day improving agitation in residual-phase…
